Infiuss Health
S21
B2BMarketplace
Active

Infiuss Health

SAAS Platform for running Clinical research and trials in Africa

Infiuss health connects US and EU-based pharma, life science companies and researchers to participants for clinical trials and research in Africa. 1.4 Billion Africans (the most diverse population on earth) are excluded from clinical research studies today because it takes on average 9-12 months to recruit participants and engage with them to take part in these studies. Leading to researchers missing out on huge data that could be generated from studying this population and also exposing us to drugs and vaccines tested on non-African participants. We are building a decentralized platform to power remote research/clinical trials in Africa, by connecting researchers (in industry and academia) directly to patients, participants for their clinical research studies in under 5days. Our all-in-one software helps researchers remotely recruit participants, collect remote consent, collect analyze data and provide virtual support. 20X faster and cheaper than third-party contract research organizations.

Melissa Bime

Melissa Bime is the co-founder of Infiuss Health. She is a RN, and has got to experience first hand the challenges patients faced across diverse health care settings in Africa. After completing Nursing school, Melissa started INFIUSS, a startup that connects life science companies to patients for clinical research and clinical trials in Africa to help ensure that Africa’s Diverse population is included in global research studies and clinical trials.

Melissa Bime
Melissa Bime
Infiuss Health

Mbah Charles

Co-founder CTO Infiuss Health. Past Microsoft and Huawei

Mbah Charles
Mbah Charles
Infiuss Health